Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

radiosensitization

  • Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy
    You have access
    Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy
    Clara Diaz Garcia-Prada, Léna Carmes, Salima Atis, Ali Parach, Alejandro Bertolet, Marta Jarlier, Sophie Poty, Daniel Suarez Garcia, Wook-Geun Shin, Stanislas Du Manoir, Jan Schuemann, Olivier Tillement, François Lux, Julie Constanzo and Jean-Pierre Pouget
    Journal of Nuclear Medicine December 1, 2023, 64 (12) 1956-1964; DOI: https://doi.org/10.2967/jnumed.123.265418
  • Antiandrogen Therapy Radiosensitizes Androgen Receptor–Positive Cancers to <sup>18</sup>F-FDG
    You have access
    Antiandrogen Therapy Radiosensitizes Androgen Receptor–Positive Cancers to 18F-FDG
    Indulekha Singaravelu, Henry Spitz, Mary Mahoney, Zhongyun Dong and Nalinikanth Kotagiri
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1177-1183; DOI: https://doi.org/10.2967/jnumed.121.262958
  • You have access
    Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study
    Shakeel Modak, Pat Zanzonico, Jorge A. Carrasquillo, Brian H. Kushner, Kim Kramer, Nai-Kong V. Cheung, Steven M. Larson and Neeta Pandit-Taskar
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 231-237; DOI: https://doi.org/10.2967/jnumed.115.161752
  • You have access
    Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer
    Vessela Vassileva, Vineeth Rajkumar, Mario Mazzantini, Mathew Robson, Adam Badar, Surinder Sharma, Erik Årstad, Daniel Hochhauser, Mark F. Lythgoe, Geoffrey M. Boxer and Rosmund Barbara Pedley
    Journal of Nuclear Medicine August 1, 2015, 56 (8) 1239-1245; DOI: https://doi.org/10.2967/jnumed.115.157362
SNMMI

© 2025 SNMMI

Powered by HighWire